These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 736694)

  • 1. Yohimbine-induced stimulus control in the rat.
    Winter JC
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):86-92. PubMed ID: 736694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1221-6. PubMed ID: 1475306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of xylazine in rat: discriminability and effects of putative alpha-2 adrenoceptor agonists and antagonists.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):521-7. PubMed ID: 2865356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.
    Winter JC
    Pharmacol Biochem Behav; 1984 Feb; 20(2):201-3. PubMed ID: 6546992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.
    Callahan PM; Appel JB
    Psychopharmacology (Berl); 1990; 100(1):13-8. PubMed ID: 2296621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD.
    Young R; Rosecrans JA; Glennon RA
    Life Sci; 1982 Jun; 30(24):2057-62. PubMed ID: 7109835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental modulation of the interoceptive effects of amphetamine in the rat.
    Paolone G; Palopoli M; Marrone MC; Nencini P; Badiani A
    Behav Brain Res; 2004 Jun; 152(1):149-55. PubMed ID: 15135978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross generalization with LSD and yohimbine in the rat.
    Colpaert FC
    Eur J Pharmacol; 1984 Jul; 102(3-4):541-4. PubMed ID: 6489439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 10. The stimulus properties of LSD in C57BL/6 mice.
    Winter JC; Kieres AK; Zimmerman MD; Reissig CJ; Eckler JR; Ullrich T; Rice KC; Rabin RA; Richards JB
    Pharmacol Biochem Behav; 2005 Aug; 81(4):830-7. PubMed ID: 16005500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.
    Winter JC; Rabin RA
    J Pharmacol Exp Ther; 1992 Nov; 263(2):682-9. PubMed ID: 1359109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.
    Sanger DJ
    Psychopharmacology (Berl); 1988; 96(2):243-9. PubMed ID: 2906748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of indorenate, a serotonin agonist.
    Velázquez-Martínez DN; López Cabrera M; Sánchez H; Ramírez JI; Hong E
    J Psychiatry Neurosci; 1999 Mar; 24(2):122-30. PubMed ID: 10212554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine-induced stimulus control.
    Winter JC
    Pharmacol Biochem Behav; 1981 Aug; 15(2):157-9. PubMed ID: 7312889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex stimulus properties of LSD: a drug discrimination study with alpha 2-adrenoceptor agonists and antagonists.
    Marona-Lewicka D; Nichols DE
    Psychopharmacology (Berl); 1995 Aug; 120(4):384-91. PubMed ID: 8539318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimuli produced by clonidine in spontaneously hypertensive rats: generalization to antihypertensive drugs with different mechanisms of action.
    Lal H; Yaden S
    J Pharmacol Exp Ther; 1985 Jan; 232(1):33-9. PubMed ID: 3965699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD, 5-HT (serotonin), and the evolution of a behavioral assay.
    Appel JB; West WB; Buggy J
    Neurosci Biobehav Rev; 2004 Jan; 27(8):693-701. PubMed ID: 15019419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.
    Rosecrans JA; Chance WT; Spencer RM
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):221-37. PubMed ID: 674812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin1B receptor ligands in the nucleus accumbens shell do not affect the discriminative stimulus effects of amphetamine in rats.
    Filip M; Nowak E; Baran L; Przegaliński E
    Pol J Pharmacol; 2001; 53(5):449-57. PubMed ID: 11990062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.